Who Owns Perrigo Company Company?

Perrigo Company Bundle

Get Bundle
Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10

TOTAL:

Who Really Owns Perrigo Company?

Uncover the forces shaping the future of a healthcare giant! Understanding Perrigo Company SWOT Analysis is key to grasping its strategic moves. From its humble beginnings to its current global presence, Perrigo's ownership structure has undergone a fascinating evolution. This deep dive explores the key players and pivotal moments that have defined Perrigo's trajectory.

Who Owns Perrigo Company Company?

Knowing who owns Perrigo Company is vital for anyone tracking its stock and understanding its long-term potential. This analysis will examine Perrigo's ownership, including its major shareholders, executives, and the influence of its board of directors. We'll also explore where Perrigo headquarters is located and how its financial performance has been shaped by its ownership structure. This investigation into Perrigo ownership will provide valuable insights for investors and those interested in the company's future, including how to buy Perrigo stock and the implications of its corporate decisions.

Who Founded Perrigo Company?

The Perrigo Company was established in 1887 in Allegan, Michigan, by Luther and Charles Perrigo. Initially, the company operated as a general store before transitioning into a packager of home remedies. This early focus on healthcare products set the stage for its future growth and development.

Details on the initial equity split or shareholding percentages of the founders are not readily available in public records. Similarly, information regarding early investors or family members who acquired stakes during this initial phase is not extensively documented. This lack of detailed early records is common for companies that started over a century ago.

The company's initial public offering (IPO) on Nasdaq in 1991 marked a significant shift in Perrigo ownership. This event broadened the ownership base beyond the founding family and early private investors, distributing shares to public and institutional investors. Specifics on early agreements, such as vesting schedules or founder exits, are not widely publicized for this early period.

Icon

Key Ownership Insights

Understanding the evolution of Perrigo ownership is crucial for investors and stakeholders. The shift from private to public ownership significantly altered the company's structure and accountability. Here are some key points:

  • The IPO in 1991 was a pivotal moment, opening the door for public investment and changing the dynamics of Perrigo shareholders.
  • Details regarding early ownership structures and founder agreements remain largely undocumented, making it difficult to ascertain the exact initial distribution of control.
  • The company's focus on accessible healthcare products likely influenced the initial distribution of control, prioritizing growth and market reach.
  • For information on the current ownership structure, including major shareholders and Perrigo executives, investors should consult the latest Perrigo Company annual reports and filings.

Perrigo Company SWOT Analysis

  • Complete SWOT Breakdown
  • Fully Customizable
  • Editable in Excel & Word
  • Professional Formatting
  • Investor-Ready Format
Get Related Template

How Has Perrigo Company’s Ownership Changed Over Time?

The evolution of Perrigo Company's ownership has been marked by significant strategic shifts. Following its initial public offering (IPO) in 1991, the company's structure underwent a major transformation in December 2013. This was due to the acquisition of Elan Corporation, plc, an Irish-based generic pharmaceuticals company, for $8.6 billion. This strategic move led to Perrigo becoming an Irish-registered company for tax purposes, with former shareholders of both companies holding substantial shares.

This acquisition was a pivotal moment, illustrating the company's efforts to optimize its financial and operational strategies. The ownership structure shifted significantly, reflecting the integration of Elan and the subsequent changes in shareholder composition. This corporate tax inversion aimed to take advantage of a more favorable tax environment, impacting the company's financial strategy and ownership dynamics.

Ownership Category Percentage of Shares (May 2025) Shareholders
Institutional Investors 58.19% Vanguard Group Inc., BlackRock, Inc., Price T Rowe Associates Inc /md/, Dimensional Fund Advisors Lp, State Street Corp., T. Rowe Price Mid-Cap Value Fund, Inc. (TRMCX), Deprince Race & Zollo Inc, iShares Core S&P Mid-Cap ETF (IJH), Vanguard Total Stock Market Index Fund Investor Shares (VTSMX), Neuberger Berman Group LLC
Insiders 0.42% Perrigo executives and board members
Public Companies and Individual Investors 28.44% Various retail and individual investors

As of June 10, 2025, major institutional shareholders collectively hold a significant number of shares, influencing the company's strategic decisions and stock performance. These include prominent investment firms like Vanguard Group Inc., BlackRock, Inc., and State Street Corp. The ownership structure of Perrigo, a publicly traded company, is primarily comprised of institutional investors, insiders, and public/individual investors, reflecting a diverse investor base.

Icon

Key Takeaways on Perrigo Ownership

The ownership of Perrigo Company is primarily held by institutional investors, with a significant portion also owned by public companies and individual investors. The company's ownership structure has evolved over time, influenced by acquisitions and strategic decisions.

  • Institutional investors hold the majority of the shares, impacting decision-making.
  • The Elan acquisition in 2013 was a pivotal moment in ownership evolution.
  • Understanding the ownership structure provides insights into the company's stability and strategic direction.
  • Perrigo is a publicly traded company, and its stock is available for purchase by investors.

Perrigo Company PESTLE Analysis

  • Covers All 6 PESTLE Categories
  • No Research Needed – Save Hours of Work
  • Built by Experts, Trusted by Consultants
  • Instant Download, Ready to Use
  • 100% Editable, Fully Customizable
Get Related Template

Who Sits on Perrigo Company’s Board?

The current board of directors of Perrigo Company plc is responsible for the company's governance and strategic direction. At the annual general meeting scheduled for May 1, 2025, eleven director nominees are up for election, each to serve until the 2026 Annual General Meeting of Shareholders. Details on which board members represent major shareholders, founders, or independent seats are typically found in the company's proxy statements. The proxy statement filed on March 21, 2025, provides information on the beneficial ownership of Perrigo ordinary shares by directors, nominees, and named executive officers as of March 3, 2025.

Recent changes to the board include Katherine Doyle's retirement as an independent director, effective at the 2025 annual general meeting, after serving since 2020. Jonas Samuelson was appointed to the board on January 15, 2025, and serves on the Audit Committee and the Nominating and Governance Committee. Past events, such as the activist investor campaign by Starboard Value LP around 2016-2017, have influenced decision-making and led to leadership changes, including the departure of former CEO John Hendrickson. For more insights, check out the Competitors Landscape of Perrigo Company.

Director Role Date of Appointment
Murray S. Kessler Chairman of the Board 2018
Ronald V. Vlasic Lead Independent Director 2013
Jonas Samuelson Director January 15, 2025

Perrigo's voting structure uses a one-share-one-vote basis for ordinary resolutions, which require a simple majority of votes cast. Special resolutions, such as those related to opting out of statutory pre-emption rights or amending the company's Articles of Association, need at least 75% of the votes cast. There is no public data suggesting dual-class shares or special voting rights that would give outsized control to specific entities beyond their shareholding. Understanding Perrigo ownership structure is key for investors.

Icon

Key Takeaways on Perrigo's Board and Voting

The board of directors oversees Perrigo Company's strategic direction and governance. The voting structure is primarily one share, one vote, with some resolutions requiring a supermajority.

  • Eleven director nominees are to be elected at the 2025 AGM.
  • Katherine Doyle retired from the board in 2025.
  • Jonas Samuelson joined the board in January 2025.
  • Past activist campaigns have influenced board decisions.

Perrigo Company Business Model Canvas

  • Complete 9-Block Business Model Canvas
  • Effortlessly Communicate Your Business Strategy
  • Investor-Ready BMC Format
  • 100% Editable and Customizable
  • Clear and Structured Layout
Get Related Template

What Recent Changes Have Shaped Perrigo Company’s Ownership Landscape?

Over the past few years, Perrigo Company has seen some shifts in its ownership. Insider holdings have slightly increased, moving from 0.20% to 0.24% as of May 2025. Institutional investors continue to hold a significant portion, approximately 58.19% of the company's stock, with mutual funds holding steady at 75.02%.

From December 2024 to March 2025, there were no share repurchases under the buyback plan announced in November 2018. However, the company has completed the repurchase of 3,400,000 shares, representing 2.49% for $164.24 million under that specific program. The company also increased its quarterly dividend to $0.29 per share, or $1.16 annually, a 5% increase, marking the 22nd consecutive year of dividend increases. These details are important for understanding the current Perrigo ownership landscape.

Metric Value Date
Insider Ownership 0.24% May 2025
Institutional Ownership 58.19% May 2025
Mutual Fund Ownership 75.02% May 2025
Dividend per Share (Annual) $1.16 2025

Several leadership changes have occurred at Perrigo. Matt Winterman was appointed Executive Vice President, Product Supply, Operations Strategy and Transformation Officer, effective June 23, 2025. Abbie Lennox was appointed Executive Vice President and Chief Scientific Officer in January 2025, and Charles Atkinson became Executive Vice President, General Counsel and Secretary in September 2024. These changes are part of the company's ongoing strategic adjustments.

Icon Perrigo's Strategy

Perrigo is currently implementing a 'Stabilize, Streamline, and Strengthen' strategy. This includes enhancing business operations and reducing net leverage.

Icon Financial Goals

The company aims for double-digit adjusted EPS growth in 2025. They expect total net sales growth of 1% to 3% for fiscal year 2025.

Icon Sales Projections

Perrigo projects an organic net sales CAGR of 2.5% to 4.5% from fiscal years 2025 to 2027.

Icon EPS Growth

Adjusted diluted EPS CAGR is projected to be in the high-single to low-double digit percentage range for fiscal years 2025 to 2027.

Perrigo Company Porter's Five Forces Analysis

  • Covers All 5 Competitive Forces in Detail
  • Structured for Consultants, Students, and Founders
  • 100% Editable in Microsoft Word & Excel
  • Instant Digital Download – Use Immediately
  • Compatible with Mac & PC – Fully Unlocked
Get Related Template

Related Blogs

Data Sources

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.